Antiviral composition containing glucosan

A dextran and anti-virus technology, which is applied in the direction of disinfectant, biocide, animal repellent, etc., can solve the problems that the compounding technology of dextran and component A has not been reported, and achieve the goal of field application The effect of reducing quantity, reducing single selection pressure, and reducing cost

Inactive Publication Date: 2018-01-09
JINGBO AGROCHEM TECH CO LTD
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, the compounding technology of dextran and component A has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antiviral composition containing glucosan
  • Antiviral composition containing glucosan
  • Antiviral composition containing glucosan

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] 11% dextran · Component A emulsifiable concentrate

[0033] Raw material composition: 1% dextran sugar, 10% component A technical drug, 5% N-methylpyrrolidone, 3% calcium dodecylbenzenesulfonate, 2% fatty alcohol ether sodium sulfate phosphate, 5% benzene Ethylphenol formaldehyde resin polyoxyethylene ether, and the rest is made up with aromatic hydrocarbon S-150. Prepared according to the conventional cream production method. The component A is (1S,3S)-N'-(4-chlorophenylmethylene)-1-methyl-2,3,4,9-tetrahydropyrido[3,4-b ] indole-3-carboxyl hydrazide.

[0034] Example 1 sample, the control agent is 0.5% dextran sugar soluble powder (commercially available) and 1% component A wettable powder (laboratory production) for comparative drug efficacy comparison test. Control objects: Tobacco mosaic disease, tomato virus disease.

[0035]

[0036] The average temperature during medication is 21-25°C, and the weather is mainly sunny. The data show that the anti-bacterial ...

Embodiment 2

[0038] 30% Dextran · Component A Suspending Concentrate

[0039] The raw material composition is: 20% dextran, 10% component A, 1% sodium lignin sulfate, 2% calcium dodecylbenzenesulfonate, 3% tristyryl phenol polyoxyethylene ether, fatty alcohol 1.0% polyoxyethylene ether, 1% magnesium aluminum silicate, 0.10% xanthan gum, 5% ethylene glycol, and make up the rest with water. Prepared according to the conventional production method of suspension concentrate. The component A is (1S,3S)-N'-(cyclohexylmethylene)-1-methyl-2,3,4,9-tetrahydropyrido[3,4-b]indole -3-Formohydrazide.

[0040] The sample of Example 2, the control agent is 0.5% dextran sugar soluble powder (commercially available) and 1% component A wettable powder (laboratory production) for comparative drug efficacy comparison test. Control objects: cucumber mosaic disease, potato shrunken mosaic disease.

[0041]

[0042] The average temperature during medication is 21-25°C, and the weather is mainly sunny. The da...

Embodiment 3

[0044] 41% dextran · component A wettable powder

[0045] The raw material composition is 1% dextran, 40% component A, 1% sodium lauryl sulfate, 7% sodium alkylphenol ethoxylate sulfonate, 2% sodium lignosulfonate, 3.5% lignin Sulfonate dispersant, the rest is supplemented with light calcium carbonate. Formulated according to conventional wettable powder production methods. The component A is (1S,3S)-N'-(cyclohexylmethylene)-1-methyl-2,3,4,9-tetrahydropyrido[3,4-b]indole -3-Formohydrazide.

[0046] The sample of Example 3, the control agent is 0.5% dextran sugar soluble powder (commercially available) and 1% component A wettable powder (laboratory production) for comparative drug efficacy comparison test. Control objects: turnip mosaic disease, potato shrunken mosaic disease.

[0047]

[0048] The average temperature during medication is 21-25°C, and the weather is mainly sunny. The data show that the anti-bacterial efficiency of the compound preparation is improved com...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of compounding of pesticides, and in particular relates to an antiviral composition containing glucosan. The antiviral composition comprises effective ingredients and auxiliary ingredients, wherein the effective ingredients are a component A and glucosan, the effective ingredients account for 1-80wt% of the antiviral composition, and the component A isa tetrahydro-beta-carboline alkaloid derivative. The antiviral composition is used for preventing and treating cruciferous vegetable virus diseases, or potato rugose mosaic, or camellia mosaic disease, or peanut stunt, or tomato virus disease or tomato gray mould. The antiviral composition provided by the invention has the advantages that the glucosan and the component A are taken as the effectiveingredients, control effect is improved, pesticide residue and environmental pollution are reduced, production of virus resistance can be beneficially avoided, and production speed of the virus resistance is slowed down.

Description

technical field [0001] The invention relates to the technical field of pesticide compounding, in particular to an antiviral composition containing dextran. Background technique [0002] Plant viral diseases pose a serious threat to crop yield and quality worldwide, causing 10-30% yield reduction and economic losses of about 20 billion U.S. dollars every year. It is widely distributed, various in variety, wide in transmission route and serious in harm. The prevention and control methods of plant virus diseases mainly include: 1) Breeding disease-resistant varieties, detoxification of seeds or vegetative bodies, using attenuated strains and satellite RNA; 2) Killing and killing biological virus transmission mediators; system, etc.; 4) chemical agent control. The comprehensive control measures centered on the promotion of disease-resistant varieties are just a preventive measure, and there are no ideal disease-resistant varieties at present. The lack of effective control agen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A01N43/90A01N43/16A01P1/00A01P3/00
Inventor 许兴志韦能春王成邓晓杰赵艳龙王宗张宗英张元珍
Owner JINGBO AGROCHEM TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products